189 related articles for article (PubMed ID: 8670221)
1. Human growth hormone deletion mutant (hGH44-191) binds with high affinity to lactogenic receptors but not to somatogenic receptors.
Haro LS; Singh RN; Lewis UJ; Martinez AO; Galosy SS; Staten NR; Krivi GG
Biochem Biophys Res Commun; 1996 May; 222(2):421-6. PubMed ID: 8670221
[TBL] [Abstract][Full Text] [Related]
2. Human growth hormone binds to lactogenic receptors in bovine, ovine and rat adrenals.
Teh LC; Ormandy CJ; Surus AS; Sutherland RL; Chapman GE
Horm Metab Res; 1988 May; 20(5):278-81. PubMed ID: 3402911
[TBL] [Abstract][Full Text] [Related]
3. Reduction of lactogenic receptors in female hamster liver due to the human growth hormone analog produced by plerocercoids of the tapeworm, Spirometra mansonoides.
Phares CK; Booth BJ
Endocrinology; 1986 Mar; 118(3):1102-9. PubMed ID: 3004894
[TBL] [Abstract][Full Text] [Related]
4. Chemical modification of human growth hormone with N-acetylimidazole. Effect on binding capacity to lactogenic and somatogenic receptors.
Kaliman P; Ermácora MR; Nowicki C; Wolfenstein-Todel C; Santomé JA
Int J Pept Protein Res; 1991 Jul; 38(1):38-46. PubMed ID: 1657805
[TBL] [Abstract][Full Text] [Related]
5. Human growth hormone fragments 1-43 and 44-191: in vitro somatogenic activity and receptor binding characteristics in human and nonprimate systems.
Rowlinson SW; Waters MJ; Lewis UJ; Barnard R
Endocrinology; 1996 Jan; 137(1):90-5. PubMed ID: 8536647
[TBL] [Abstract][Full Text] [Related]
6. Site-directed mutagenesis of recombinant bovine placental lactogen at lysine-73 leads to selective attenuation of its somatogenic activity.
Helman D; Staten NR; Byatt J; Grosclaude J; McKinnie RE; Djiane J; Gertler A
Endocrinology; 1997 Oct; 138(10):4069-80. PubMed ID: 9322914
[TBL] [Abstract][Full Text] [Related]
7. Somatogenic and lactogenic activity of the recombinant 22 kDa isoform of human placental growth hormone.
Igout A; Frankenne F; L'Hermite-Balériaux M; Martin A; Hennen G
Growth Regul; 1995 Mar; 5(1):60-5. PubMed ID: 7749349
[TBL] [Abstract][Full Text] [Related]
8. Ovine placental lactogen and human growth hormone bind to different regions of the same receptors.
Longhi SA; Wolfenstein-Todel C; Gómez KA; Miranda ME; Retegui LA
Growth Horm IGF Res; 1999 Jun; 9(3):157-64. PubMed ID: 10502451
[TBL] [Abstract][Full Text] [Related]
9. Identification of somatogenic binding sites in liver microsomes from normal mice and transgenic mice expressing human growth hormone gene.
Aguilar RC; Fernández HN; Dellacha JM; Calandra RS; Bartke A; Turyn D
Life Sci; 1992; 50(9):615-20. PubMed ID: 1740969
[TBL] [Abstract][Full Text] [Related]
10. Lactogenic and somatogenic binding sites in intact and detergent-solubilized membrane preparations of female rat liver.
Haldosén LA; Gustafsson JA
Biochem J; 1988 Jun; 252(2):509-14. PubMed ID: 3415671
[TBL] [Abstract][Full Text] [Related]
11. Mouse liver specific uptake of iodinated growth hormones: evidence for the presence of somatogenic and lactogenic sites.
Ciccia-Torres GN; Turyn D; Dellacha JM
Horm Metab Res; 1983 Sep; 15(9):443-8. PubMed ID: 6315559
[TBL] [Abstract][Full Text] [Related]
12. Modulation of human growth hormone binding to somatogenic and lactogenic receptors by monoclonal antibodies to human growth hormone.
Amit T; Barkey RJ; Youdim MB; Hochberg Z
Cell Signal; 1992 Sep; 4(5):553-8. PubMed ID: 1419491
[TBL] [Abstract][Full Text] [Related]
13. Structure-function studies on human growth hormone. Evidence that tertiary structure is essential for biological activity.
Aubert ML; Bewley TA; Grumbach MM; Kaplan SL; Li CH
Int J Pept Protein Res; 1986 Jul; 28(1):45-57. PubMed ID: 2944851
[TBL] [Abstract][Full Text] [Related]
14. Characterization of somatogenic and lactogenic binding sites in isolated rat hepatocytes.
Ranke MB; Stanley CA; Tenore A; Rodbard D; Bongiovanni AM; Parks JS
Endocrinology; 1976 Oct; 99(4):1033-45. PubMed ID: 185044
[TBL] [Abstract][Full Text] [Related]
15. Allosteric effects of monoclonal antibodies on human growth hormone.
Aguilar RC; Retegui LA; Postel-Vinay MC; Roguin LP
Mol Cell Biochem; 1994 Jul; 136(1):35-42. PubMed ID: 7531816
[TBL] [Abstract][Full Text] [Related]
16. [Characterization and solubilization of specific growth hormone binding sites in the rat liver].
du Caju M; Postel-Vinay MC; Desbuquois B
Arch Fr Pediatr; 1978 Dec; 35(10 Suppl):102-14. PubMed ID: 219801
[TBL] [Abstract][Full Text] [Related]
17. Differential in vivo activities of bovine growth hormone analogues.
Kopchick J; Chen XZ; Li Y; Steger RW; Yun JS; Wagner TE; Bartke A
Transgenic Res; 1998 Jan; 7(1):61-71. PubMed ID: 9556914
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of lactogenic activities of ovine prolactin and human growth hormone (hGH) by a novel form of a modified recombinant hGH.
Gertler A; Shamay A; Cohen N; Ashkenazi A; Friesen HG; Levanon A; Gorecki M; Aviv H; Hadary D; Vogel T
Endocrinology; 1986 Feb; 118(2):720-6. PubMed ID: 2417826
[TBL] [Abstract][Full Text] [Related]
19. Human growth hormone-variant demonstrates a receptor binding profile distinct from that of normal pituitary growth hormone.
Ray J; Okamura H; Kelly PA; Cooke NE; Liebhaber SA
J Biol Chem; 1990 May; 265(14):7939-44. PubMed ID: 2335510
[TBL] [Abstract][Full Text] [Related]
20. Analysis of growth hormone and lactogenic binding sites cross-linked to iodinated human growth hormone.
Hughes JP; Simpson JS; Friesen HG
Endocrinology; 1983 Jun; 112(6):1980-5. PubMed ID: 6303751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
